---
figid: PMC5835759__fphar-09-00168-g001
figtitle: Interactions among Protein Kinase C Alpha (PRKCA), NOS3, and BDKRB2 gene
  products within the ACE inhibitor pathway may affect the antihypertensive response
  to enalapril
organisms:
- NA
pmcid: PMC5835759
filename: fphar-09-00168-g001.jpg
figlink: /pmc/articles/PMC5835759/figure/F1/
number: F1
caption: (A) Interactions among Protein Kinase C Alpha (PRKCA), NOS3, and BDKRB2 gene
  products within the ACE inhibitor pathway may affect the antihypertensive response
  to enalapril. Protein kinase C alpha (PKCα) upregulates the endothelial nitric oxide
  synthase (eNOS) activity, leading to enhanced nitric oxide (NO) production and vasodilation.
  Moreover, stimulating bradykinin receptors on endothelial cells may result in eNOS
  upregulation mediated by PKCα. (B) Interactions among genes of the visfatin/NAMPT
  pathway and response to nifedipine in preeclampsia. NAMPT was associated with antihypertensive
  response in preeclampsia depending on TIMP1 and MMP2 genotypes. Nifedipine may affect
  circulating MMP levels in hypertension. Nifedipine and visfatin/NAMPT increase PI3K/Akt
  pathway and eNOS activity, resulting in enhanced NO production. Ang I, Angiotensin
  I; Ang II, Angiotensin II; AGTR1, Angiotensin II Receptor Type 1; KNG, Kininogen.
papertitle: 'Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene–Gene
  Interactions.'
reftext: Marcelo R. Luizon, et al. Front Pharmacol. 2018;9:168.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9631389
figid_alias: PMC5835759__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5835759__F1
ndex: d130e52b-deb9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5835759__fphar-09-00168-g001.html
  '@type': Dataset
  description: (A) Interactions among Protein Kinase C Alpha (PRKCA), NOS3, and BDKRB2
    gene products within the ACE inhibitor pathway may affect the antihypertensive
    response to enalapril. Protein kinase C alpha (PKCα) upregulates the endothelial
    nitric oxide synthase (eNOS) activity, leading to enhanced nitric oxide (NO) production
    and vasodilation. Moreover, stimulating bradykinin receptors on endothelial cells
    may result in eNOS upregulation mediated by PKCα. (B) Interactions among genes
    of the visfatin/NAMPT pathway and response to nifedipine in preeclampsia. NAMPT
    was associated with antihypertensive response in preeclampsia depending on TIMP1
    and MMP2 genotypes. Nifedipine may affect circulating MMP levels in hypertension.
    Nifedipine and visfatin/NAMPT increase PI3K/Akt pathway and eNOS activity, resulting
    in enhanced NO production. Ang I, Angiotensin I; Ang II, Angiotensin II; AGTR1,
    Angiotensin II Receptor Type 1; KNG, Kininogen.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACE
  - NAMPT
  - KNG1
  - MMP2
  - TIMP1
  - ANGPT2
  - VPS51
  - AKT1
  - AKT2
  - AKT3
  - NOS3
  - ENO4
  - PRKCA
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AGTR1
  - BDKRB2
  - Nifedipine
  - Visfatin
  - NAMPT
  - Bradykinin
---
